The charts, technical indicators, and signals here are generated live from Tech Trader, a fully autonomous trading system with no human intervention.
The second chart (if available) is a combination of Tech Trader with the Grok AI (from xAI) interpreting the chart and making trading decisions, including elaborate reports at the bottom explaining any given day.
Follow trades and activity on The Tech Trader Wall and Tech Trader + Grok Wall.
Daily Chart
(Technical analysis chart by Tech Trader)
Grok's Analysis
| 2026-01-13 | SOLD |
| 2026-01-12 | HOLD LONG |
|
Summary: Hold long; pre-earnings momentum builds with $605 test, Zacks strong buy rating and institutional stability intact....
|
|
| 2026-01-09 | HOLD LONG |
|
Summary: Hold long; after-hours slip on thin volume shrugged off by Zacks earnings beat potential and $631 buy consensus....
|
|
| 2026-01-08 | HOLD LONG |
|
Summary: Hold long; Q4 earnings preview strong (EPS $5.57/rev $10.57B est. Jan 28), StockInvest buy signal $613 target amid ATH test....
|
|
| 2026-01-07 | HOLD LONG |
|
Summary: Hold long; stacked SMAs/green MACD/solid RS per charts, Railway Pension +174% stake to 318k shares outweigh NORTHSTAR trim....
|
|
| 2026-01-06 | HOLD LONG |
|
Summary: Hold long; Robeco +233k shares (44% hike), Stevens new stake, BofA $700 PT signal strong institutional conviction....
|
|
| 2026-01-05 | HOLD LONG |
|
Summary: Hold long; TMO pushes $592 on Jan 3 volume surge, Wolfe/Jefferies PTs ($680/$650) and sector rotation back healthcare leaders....
|
|
| 2026-01-02 | HOLD LONG |
|
Summary: Hold long; markets kick off 2026 with Dow/S&P gains, TMO Buy consensus $631 target and technical uptrend hold firm....
|
|
| 2025-12-31 | HOLD LONG |
|
Summary: Hold long; Piper Sandler upgrades to Overweight $710 PT, BlackRock Q4 +200k shares ignite fresh leg higher....
|
|
| 2025-12-30 | HOLD LONG |
|
Summary: Hold long; Wolfe Research starts Outperform $680 PT, Vanguard Q4 stake hike + Vanguard flows signal institutional conviction....
|
|
| 2025-12-29 | HOLD LONG |
|
Summary: Hold long; Jefferies initiates Buy $650 PT today, Swedbank/Geneos adds and PPD Alzheimer's data momentum drive post-holiday surge....
|
|
| 2025-12-26 | HOLD LONG |
|
Summary: Maintaining the long position as the uptrend remains confirmed with price above rising EMA and SMA, positive MACD, no volume capitulation or immediate catalysts to exit, and targeting resistance near 598 while adhering to minimum hold periods....
|
|
| 2025-12-24 | BUY |
|
Summary: Entering long on this dip in a confirmed uptrend with price above rising EMA and SMA, positive MACD, and no immediate catalysts, targeting resistance near 598 over the next few weeks. Technical indicators support this: MACD is positive at 0.8567 above its signal line, RSI at 53.22 is neutral (not overbought), STO is rising, and Bollinger Bands are narrowing but price is near the upper band, suggesting potential for continuation. No volume capitulation needed here as we're not in a downtrend, and the lack of "!" or "BOT" flags aligns with steady volume without panic selling....
|
|
| 2025-12-23 | CASH |
|
Summary: Staying in cash as TMO's uptrend persists but current price near recent highs without a clear dip, bearish MACD crossover, and no strong bullish catalysts justify entry now, with next earnings around late January 2026....
|
|
| 2025-12-22 | CASH |
|
Summary: Staying in cash as TMO's uptrend persists but bearish MACD crossover and recent rejection near 598 resistance suggest potential pullback, with no strong bullish catalysts or volume capitulation to justify quick re-entry after the 12/12 exit due to similar fading momentum....
|
|
| 2025-12-19 | CASH |
|
Summary: Staying in cash as the trend is unclear with EMA and SMA tightly bound and price crossing them multiple times recently without volume capitulation, while technicals show neutral RSI, bearish MACD crossover, and price churning sideways near falling resistance around 569-576, offering no high-confidence long setup in this biotech stock where shorting is avoided....
|
|
| 2025-12-18 | CASH |
|
Summary: Staying in cash as TMO's trend is unclear with price below both EMA and SMA, which are moving sideways without a defined uptrend or volume capitulation to justify a long entry, while resistance at 598 caps upside and no immediate catalysts support a trade....
|
|
| 2025-12-17 | CASH |
|
Summary: Staying in cash as the trend is unclear with price below both EMA and SMA, recent rejection at $598 resistance, bearish MACD crossover, and no volume capitulation or strong catalysts to justify entry, while avoiding shorts on this biotech stock....
|
|
| 2025-12-16 | CASH |
|
Summary: Staying in cash as the trend is unclear with price below EMA despite EMA above SMA, recent resistance rejection at 598 signaling potential further pullback to 550 support, no volume capitulation or bullish catalysts, and history of losses on premature long entries in similar choppy conditions. MACD is bearish with the line below the signal (1.3994 < 4.0423), STO is oversold but without conviction for a rebound, and RSI at 45.64 suggests neutral momentum leaning weak. There's no recent volume capitulation flagged, and the past two months lack "!" or "BOT" indicators to justify buying a dip in what could be interpreted as a downtrend pause....
|
|
| 2025-12-15 | CASH |
|
Summary: Staying in cash as the uptrend persists but bearish MACD signals caution after recent rejection at 598 resistance and our quick exit on 12/12 due to fading momentum, with no new catalysts or volume capitulation to justify re-entry so soon despite a slight price recovery....
|
|
| 2025-12-12 | SOLD |
|
Summary: Exiting the long position in TMO as price has rejected at 598 resistance with bearish MACD crossover below signal, overbought conditions fading, and pullback toward 550 support signaling potential further downside over the next few weeks, despite intact uptrend....
|
|
| 2025-12-11 | HOLD LONG |
|
Summary: Staying long in TMO as the uptrend continues with EMA above SMA and both rising, price above key 550 support despite a mild pullback, no earnings or catalysts imminent, and positive sector tailwinds from medtech demand....
|
|
| 2025-12-10 | HOLD LONG |
|
Summary: Staying long in TMO as the uptrend persists with EMA above SMA and both rising, price holding above 550 support amid a pullback, no immediate catalysts or earnings, and positive medtech sector momentum from recent acquisitions and demand. No volume capitulation in the last two months, but that's not required here since we're already positioned in an uptrend. MACD is below its signal line (2.80 vs 6.68), indicating some bearish momentum, but this hasn't broken key supports, and RSI at 49 suggests neutral conditions without oversold signals to prompt an exit. STO is low at 18.7, hinting at potential rebound, and Bollinger Bands are contracting (upper 597.53, lower 561.31), often preceding volatility—likely upward given the trend....
|
|
| 2025-12-09 | HOLD LONG |
|
Summary: Staying long in TMO as the uptrend continues with EMA above SMA and both rising, price pulling back but holding above key support at 550 without breakdowns or catalysts, supported by positive medtech sector trends and no near-term earnings. ...
|
|
| 2025-12-08 | HOLD LONG |
|
Summary: Staying long in TMO as the overall uptrend persists with rising EMA and SMA despite the recent pullback below EMA, solid support at 550 holding, positive healthcare sector momentum from medtech demand, and no immediate catalysts or breakdowns signaling an exit after only 5 bars....
|
|
| 2025-12-05 | HOLD LONG |
|
Summary: Staying long in TMO as the uptrend holds with price above rising EMA and SMA, positive fundamentals in healthcare sector, no near-term catalysts, and support at 550 intact while targeting resistance near 600-610 despite recent pullback. MACD is positive at 6.41 but below the signal at 9.6, indicating some fading momentum after the November run-up to 597.78, yet no bearish crossover invalidates the trend; RSI at 49.08 is neutral, avoiding overbought conditions, and Slow STO K/D at 36.20/52.25 suggests room for recovery without immediate downside pressure....
|
|
| 2025-12-04 | HOLD LONG |
|
Summary: Staying long in TMO as the uptrend persists with price above rising EMA and SMA, positive MACD momentum despite recent pullback, no immediate catalysts or earnings, and targeting resistance near 610 while support at 550 holds firm....
|
|
| 2025-12-03 | HOLD LONG |
|
Summary: Staying long in TMO as the uptrend holds with price above rising EMA and SMA, positive overall momentum despite minor pullback, no immediate earnings or catalysts, and targeting resistance near 610 while support at 550 remains intact. The chart shows a confirmed uptrend: EMA at 570.60 is above SMA at 552.50, price at 581.20 is above both, and both averages are trending upward without frequent crossings or sideways movement in the past month. MACD is at 9.11 with signal at 11.06, indicating a recent bearish crossover, but the overall trend remains positive with no breakdown below key levels; RSI at 55.97 is neutral, and Slow STO K/D at 57.69/67.33 suggests some overbought unwinding but not extreme....
|
|
| 2025-12-02 | HOLD LONG |
|
Summary: Staying long in TMO as the position is only one bar old, uptrend remains confirmed with price above rising EMA and SMA, positive MACD overall trend despite minor pullback, no immediate earnings or catalysts, and targeting resistance near 610 with support at 550 holding firm....
|
|
| 2025-12-01 | BUY |
|
Summary: Entering long on this dip in a confirmed uptrend with price above rising EMA and SMA, positive MACD momentum, and no immediate catalysts or overbought signals, targeting resistance near 610 over the next few weeks....
|
|
| 2025-11-28 | SOLD |
|
Summary: Exiting the long position in TMO as price shows rejection near resistance at 598 with overbought RSI above 70, bearish MACD divergence, and fading momentum after recent highs, locking in gains while uptrend remains but no fresh catalysts support holding....
|
|
| 2025-11-26 | HOLD LONG |
|
Summary: Holding the long position in TMO as the uptrend persists with price above rising EMA and SMA, recent breakout momentum, no breach of support near 567-573, and targeting higher resistance around 610 amid positive sector sentiment and no near-term earnings....
|
|
| 2025-11-25 | HOLD LONG |
|
Summary: Holding the long position in TMO as the uptrend continues with price above rising EMA and SMA, positive momentum from recent highs, no break below support near 566-570, and targeting resistance around 600-610 amid favorable biotech sector news and no immediate earnings....
|
|
| 2025-11-24 | HOLD LONG |
|
Summary: Holding the long position in TMO as the uptrend persists with price above rising EMA and SMA, positive MACD despite recent dip, no break below support at 566-570, and targeting resistance near 600 amid stable biotech sector and no immediate catalysts....
|
|
| 2025-11-21 | HOLD LONG |
|
Summary: Holding the long position in TMO as the uptrend continues with price above rising EMA and SMA, positive MACD momentum, no break below support near 566-570, and targeting resistance around 600 amid favorable biotech sector trends and no immediate catalysts....
|
|
| 2025-11-20 | HOLD LONG |
|
Summary: Holding the long position in TMO as the uptrend persists with price above rising EMA and SMA, positive MACD momentum building, no break below support at 566, and aiming for resistance near 600 amid stable biotech trends and no near-term catalysts....
|
|
| 2025-11-19 | HOLD LONG |
|
Summary: Continuing to hold the long position in TMO as the uptrend remains intact with price above rising EMA and SMA, positive MACD despite recent pullback, no breakdowns below key support near 566, and aiming for resistance around 600 supported by strong biotech sector trends and no immediate catalysts....
|
|
| 2025-11-18 | HOLD LONG |
|
Summary: Holding long in TMO as the uptrend persists with price above rising EMA and SMA, positive MACD, no breakdowns below key supports near 566, and targeting resistance around 600 amid favorable biotech sector momentum....
|
|
| 2025-11-17 | HOLD LONG |
|
Summary: Holding long in TMO as the uptrend remains intact with EMA above SMA, price above both and moving upward, positive MACD momentum despite recent pullback, no breakdowns or negative catalysts, targeting resistance near 600 over the next few weeks. The pullback from the entry at 588.02 to 569.7 appears as a healthy dip within the uptrend, supported by rising support trendlines around 569-570, and no volume capitulation suggesting the end of upside. MACD is positive at 13.23 but below signal at 14.86, indicating fading momentum short-term, yet the histogram remains constructive without divergence; STO at 69.46 is neutral, not overbought. RSI at 57.90 shows room to run without exhaustion....
|
|
| 2025-11-14 | HOLD LONG |
|
Summary: Holding long in TMO despite minor pullback from 588.02 entry to 582.14 as uptrend persists with EMA above SMA, price above both and moving upward, positive MACD momentum, and no breakdowns or catalysts, targeting resistance near 610 over the next few weeks....
|
|
| 2025-11-13 | HOLD LONG |
|
Summary: Holding long in TMO as the uptrend persists with EMA above SMA, price above both and breaking recent highs toward resistance at 610, supported by positive MACD and no immediate catalysts or breakdowns after the entry at 588.02 despite minor pullback to 587.69....
|
|
| 2025-11-12 | BUY |
|
Summary: Entering long on continued uptrend strength with price breaking above prior resistance near 576, positive MACD momentum, and no immediate catalysts or overbought signals warranting caution, targeting higher levels around 600 over the next few weeks while justifying quick re-entry since the 11/4 exit due to the sustained breakout and lack of pullback invalidating previous rejection concerns....
|
|
| 2025-11-11 | CASH |
|
Summary: Price is at overbought highs near falling resistance at 585 with bearish MACD crossover and no volume capitulation, indicating risk of pullback in this uptrend despite strong fundamentals; staying in cash to await a dip for better entry. Recent bars reveal a strong rally from October lows around 462 to the current close at 584.54, testing the falling resistance trendline at 585.85 (strength 2.2655 with 3 bounces), which has historically capped advances, as seen in similar rejections in September and October data points. RSI at 73.62 signals overbought conditions, STO K at 94.15 is extremely elevated, and MACD (15.0353) is below its signal line (15.3897), confirming a bearish crossover that often precedes pullbacks in this stock's history, like the drop after the 11/4 exit at 565 near 576 resistance....
|
|
| 2025-11-10 | CASH |
|
Summary: Staying in cash as TMO is testing falling resistance at $583.66 with overbought STO at 91 and MACD showing fading momentum near highs, mirroring past rejections leading to pullbacks, despite uptrend and no immediate catalysts....
|
|
| 2025-11-07 | CASH |
|
Summary: The stock remains in a confirmed uptrend but is overbought with STO above 80, MACD below its signal line indicating weakening momentum, and price rejecting at the falling resistance trendline around $577, prompting caution to wait for a dip for better long entry rather than chasing near highs....
|
|
| 2025-11-06 | CASH |
|
Summary: The stock remains in a confirmed uptrend with price above rising EMA and SMA, but after recent exit on rejection near falling resistance at 576 with bearish MACD crossover and overbought STO, current levels near 566 offer poor risk/reward for immediate re-entry without a deeper dip or new bullish catalyst, so staying in cash to avoid whipsaw and wait for better setup....
|
|
| 2025-11-05 | CASH |
|
Summary: Staying in cash as the stock remains near falling resistance at 576 with persistent bearish MACD crossover and overbought STO, lacking a clear dip in the uptrend for high-confidence long re-entry soon after the 11/4 exit, while shorting is avoided for this biotech stock....
|
|
| 2025-11-04 | SOLD |
|
Summary: Exiting the long position in TMO as price shows rejection near falling resistance at 576 with MACD bearish crossover below signal, overbought STO at 80, and no fresh bullish catalysts to push higher, locking in near break-even after minimum hold while uptrend remains but momentum fades....
|
|
| 2025-11-03 | HOLD LONG |
|
Summary: Continuing the long position in TMO as the uptrend persists with price above rising EMA and SMA, positive MACD momentum, no bearish catalysts or resistance breaches, and targeting 579-585 while monitoring pullbacks....
|
|
| 2025-10-31 | HOLD LONG |
|
Summary: Continuing the long position in TMO as the uptrend remains strong with price above rising EMA and SMA, positive MACD despite minor signal crossover, and no compelling bearish catalysts or resistance breaches yet, targeting 579-585 while monitoring for sustained weakness. Volume has been supportive during advances, and there's no sign of capitulation or breakdown below key supports like the rising trendline at ~537; instead, recent dips have found buyers, as seen in the bounce from 556 to 569....
|
|
| 2025-10-30 | HOLD LONG |
|
Summary: Continuing the long position in TMO as the uptrend persists with price above rising EMA and SMA, positive MACD, and sustained bullish momentum from recent earnings beat, targeting resistance near $579-$585 while weathering minor pullbacks....
|
|
| 2025-10-29 | HOLD LONG |
|
Summary: Continuing the long position in TMO as the uptrend remains strong with price above rising EMA and SMA, positive MACD divergence, and bullish momentum from recent earnings beat targeting resistance around $579-$585, while ignoring minor pullbacks without breakdown....
|
|
| 2025-10-28 | HOLD LONG |
|
Summary: Continuing the long position in TMO as the uptrend persists with price above rising EMA and SMA, positive MACD, and post-earnings momentum aiming for resistance near $579, despite a minor pullback to $555.76. MACD remains bullish at 18.46 above the signal line at 17.26, and RSI at 63.51 indicates room for upside without overbought conditions. The recent pullback from $572.50 to $555.76 appears as a healthy dip within the uptrend, testing support near the rising trendline around $526.60 (last tested 20 bars ago with strength 0.16775), but price held above it without breaking lower for 5 consecutive bars, suggesting no invalidation....
|
|
| 2025-10-27 | HOLD LONG |
|
Summary: Continuing the long position in TMO as the uptrend remains intact with price above rising EMA and SMA, positive MACD, and sustained post-earnings momentum targeting resistance near $579, despite a minor pullback....
|
|
| 2025-10-24 | HOLD LONG |
|
Summary: Continuing the long position in TMO's strong uptrend with price above rising EMA/SMA, bullish MACD divergence, overbought RSI but sustained momentum post-earnings, targeting resistance at $579 amid positive healthcare sector trends and no near-term catalysts....
|
|
| 2025-10-23 | HOLD LONG |
|
Summary: Continuing the long position in TMO's confirmed uptrend post-earnings gap-up, with price above rising EMA and SMA, bullish MACD, and momentum targeting resistance near $579, supported by positive sector news and no immediate catalysts....
|
|
| 2025-10-22 | BUY |
|
Summary: Entering long on post-earnings strength in a confirmed uptrend with price above EMA and SMA, bullish MACD, and positive momentum targeting higher resistance near $579 over the next few weeks, justified by the recent earnings beat and gap-up breakout providing new bullish catalyst since the precautionary exit on 10/20....
|
|
| 2025-10-21 | CASH |
|
Summary: Staying in cash due to upcoming earnings on 10/22/2025, with the chart showing an uptrend but no high-confidence entry setup without risking volatility, and no other immediate catalysts identified....
|
|
| 2025-10-20 | SOLD |
|
Summary: Exiting the long position ahead of earnings on 10/22/2025 to avoid volatility, as it doesn't qualify for holding through based on historical surprises, while the uptrend remains intact with price above EMA/SMA and positive MACD, but no other catalysts justify the risk....
|
|
| 2025-10-17 | HOLD LONG |
|
Summary: Holding the long position as the uptrend continues with price above EMA and SMA, positive MACD, no breakdowns, and earnings on 10/22/2025 still more than 3 days away without qualifying to hold through....
|
|
| 2025-10-16 | HOLD LONG |
|
Summary: Holding the long position as the uptrend persists with price above EMA and SMA, positive MACD momentum, no breakdowns near resistance, and earnings on 10/22/2025 still over 3 days away without qualifying to hold through based on historical reactions....
|
|
| 2025-10-15 | HOLD LONG |
|
Summary: Holding the long position as the uptrend remains intact with price above EMA and SMA, positive MACD, no immediate catalysts or breakdowns, and sufficient time before 10/22/2025 earnings to capture more upside....
|
|
| 2025-10-14 | HOLD LONG |
|
Summary: TMO shows strong institutional buying, a moderate buy rating with a $585 target, and expected earnings growth, making it wise to hold the long position....
|
|
| 2025-10-13 | HOLD LONG |
|
Summary: Continuing to hold the long position as technicals remain supportive with price above EMA and SMA, positive MACD, and sufficient time before earnings to capture more upside, despite recent pullback....
|
|
| 2025-10-10 | HOLD LONG |
|
Summary: Holding the long position as the uptrend remains intact with price above EMA and SMA, positive MACD, no bearish reversals, and time before earnings on 10/22/2025 allows for further upside potential....
|
|
| 2025-10-09 | HOLD LONG |
|
Summary: Holding the long position as the uptrend continues with price above EMA and SMA, positive MACD momentum, no bearish reversal signals, and sufficient time before next earnings on 10/22/2025 for potential further upside....
|
|
| 2025-10-08 | HOLD LONG |
|
Summary: Holding the long position as the uptrend persists with price above EMA and SMA, bullish MACD crossover, no clear bearish reversal on the chart, and next earnings on 10/22/2025 providing room for further gains before considering an exit closer to the date....
|
|
| 2025-10-07 | HOLD LONG |
|
Summary: Holding the long position as the uptrend remains strong with price above EMA and SMA, bullish MACD, no bearish reversal signals, and next earnings on 10/22/2025 still weeks away allowing for further upside potential....
|
|
| 2025-10-06 | HOLD LONG |
|
Summary: Holding the long position as the strong uptrend continues with price well above EMA and SMA, bullish MACD crossover and high volume supporting the recent gap up, no immediate resistance or bearish catalysts, and next earnings on 10/22/2025 still allowing for minimum hold duration. Momentum indicators are supportive: MACD at 12.81 above its signal line at 4.78 indicates strong bullish momentum, RSI at 71.79 is overbought but not extreme enough to signal reversal in this context, and Slow STO K at 85.56 with D at 65.06 suggests continued upward pressure. Volume on the gap day was high at over 6 million shares, validating the breakout, and subsequent days show sustained buying interest without capitulation signals....
|
|
| 2025-10-03 | HOLD LONG |
|
Summary: Holding the long position as the strong uptrend persists with price above EMA and SMA, bullish MACD, high volume gap confirmation, and no near-term resistance or catalysts demanding exit, with next earnings on 10/22/2025....
|
|
| 2025-10-02 | HOLD LONG |
|
Summary: Holding the long position as the recent gap up on high volume confirms a strong uptrend with price above both EMA and SMA, bullish MACD, and no immediate resistance or catalysts warranting an exit, targeting further upside over the coming weeks with next earnings on 10/22/2025....
|
|
| 2025-10-01 | BUY |
|
Summary: Entering long on the massive gap up breakout above resistance on high volume, confirming a new uptrend with bullish MACD crossover and positive momentum, targeting higher levels over the next few weeks despite recent losses, with next earnings on 10/22/2025....
|
|
| 2025-09-30 | CASH |
|
Summary: Staying in cash due to unclear trend with EMA below SMA despite price above both, recent price crossings of averages, no volume capitulation, and repeated losses on prior longs from pullbacks, while awaiting confirmation of uptrend for a high-confidence entry targeting resistance at $496.5....
|
|
| 2025-09-29 | CASH |
|
Summary: Staying in cash as TMO is in a downtrend with price below both EMA and SMA, no volume capitulation to justify a long entry, and as a biotech stock it cannot be shorted, while recent pullbacks show risk of further downside without clear reversal signals....
|
|
| 2025-09-26 | SOLD |
|
Summary: Exiting the long position as price remains below both EMA and SMA in an unclear trend with bearish MACD, no volume capitulation, and failure to rebound toward 496 resistance, locking in the loss to await a clearer setup. MACD is bearish at -2.94, below the signal line, and RSI at 42.52 suggests neutral to oversold conditions but no strong reversal signal. Volume on the latest bar is average at 1.23M, with no capitulation flagged in the past month to support a bottom....
|
|
| 2025-09-25 | HOLD LONG |
|
Summary: Holding the long position as the chart shows price stabilizing near support after a pullback in an unclear trend with EMA slightly above SMA, no volume capitulation, bearish MACD but potential rebound to 496 resistance, and minimum hold period not yet met despite recent dip below key levels....
|
|
| 2025-09-24 | HOLD LONG |
|
Summary: Holding the long position as the minimum hold period hasn't been met yet, despite price dipping below key support at 472 and both EMA/SMA amid unclear trend signals, with no volume capitulation and bearish MACD suggesting caution but potential for rebound targeting 496 resistance....
|
|
| 2025-09-23 | HOLD LONG |
|
Summary: Holding the long position as price holds above SMA near key support at 472 without confirmed breakdown, EMA remains above SMA suggesting potential uptrend continuation, targeting resistance at 496 over the coming weeks despite bearish MACD and recent pullback....
|
|
| 2025-09-22 | HOLD LONG |
|
Summary: Holding the long position as the uptrend persists with EMA above SMA, price near key support without breaking down, targeting resistance at $496, despite recent pullback and bearish MACD, with no immediate catalysts or volume capitulation signaling reversal. Price closed at $475.47, above SMA ($471.46) but below EMA ($478.19), indicating a pullback in an uptrend rather than a downtrend shift, as there's no sustained price below both averages or volume capitulation to confirm a reversal. Technicals like RSI at 47.71 suggest neutral momentum, not oversold, while MACD (0.8589 below signal 3.2219) shows bearish divergence, but this was noted in the entry rationale and hasn't worsened dramatically. Bollinger Bands are contracting (upper $496.81, lower $471.74), pointing to a rangebound phase, with price near the lower band but holding above recent support around $470-472 from mid-September lows....
|
|
| 2025-09-19 | HOLD LONG |
|
Summary: Holding the long position as the uptrend remains intact with price above both EMA and SMA, no frequent crossings, and targeting resistance at $496, despite bearish MACD, with no immediate earnings or catalysts....
|
|
| 2025-09-18 | BUY |
|
Summary: Entering long on this bounce back above EMA in a confirmed uptrend after a brief pullback, with price above both EMA and SMA, no frequent crossings, positive MACD momentum, and no immediate earnings or catalysts, targeting resistance near $496 over the next few weeks while avoiding quick re-entry pitfalls from yesterday's exit justified by the sharp recovery and improved technicals....
|
|
| 2025-09-17 | SOLD |
|
Summary: Exiting the long position as price has broken below the EMA in an unclear trend with bearish MACD crossover and no volume capitulation to support a rebound, locking in the loss to avoid further downside while awaiting a clearer setup....
|
|
| 2025-09-16 | HOLD LONG |
|
Summary: Maintaining the long position as the uptrend continues with EMA above SMA and price above both, recent pullback finding support near $470 without breakdown, and no imminent catalysts or volume capitulation signaling reversal, despite minor unrealized loss....
|
|
| 2025-09-15 | HOLD LONG |
|
Summary: Maintaining the long position as the overall uptrend from July earnings persists despite the recent pullback to support near $472, with EMA still above SMA, no breakdowns or volume capitulation signaling reversal, and no major catalysts imminent....
|
|
| 2025-09-12 | HOLD LONG |
|
Summary: Maintaining the long position as the uptrend persists with EMA above SMA and price above both, no volume capitulation or breakdowns below key supports, recent pullback from resistance at $496.5 appears as a healthy dip without bearish reversal signals, and no earnings or major catalysts in the next 3 days....
|
|
| 2025-09-11 | HOLD LONG |
|
Summary: Maintaining the long position as the uptrend continues with EMA above SMA and price above both, recent bounce from support showing strength, approaching resistance at $496.5 but no immediate sell signals after short hold, and no earnings or catalysts in next 3 days....
|
|
| 2025-09-10 | HOLD LONG |
|
Summary: Maintaining the long position as the uptrend persists with EMA above SMA and price near support levels showing historical bounce potential, no volume capitulation or breakdowns, and no immediate catalysts warranting exit after only a short hold....
|
|
| 2025-09-09 | HOLD LONG |
|
Summary: Maintaining the long position as the uptrend remains intact with price above EMA and SMA, despite a minor pullback, supported by no immediate catalysts or breakdowns and historical resilience after dips....
|
|
| 2025-09-08 | BUY |
|
Summary: Entering long at $485.7 on this dip in a confirmed uptrend with price above both EMA and SMA, following a pullback from resistance near $496.5, offering a better entry price than the recent exit at $492.6; re-entering soon justified by the sharp price correction providing improved risk/reward while technicals remain supportive....
|
|
| 2025-09-05 | SOLD |
|
Summary: Exiting the long position as price hit new highs near resistance at $496.5 but closed lower with rejection, MACD showing bearish momentum below signal line, and uptrend intact but overbought conditions suggesting potential pullback, locking in gains after minimum hold period....
|
|
| 2025-09-04 | HOLD LONG |
|
Summary: Holding the long position as the uptrend continues with price above EMA and SMA, approaching resistance at $496.5 but not yet reached, positive MACD momentum building, no earnings or catalysts within 3 days, and stable sector without major bearish news....
|
|
| 2025-09-03 | HOLD LONG |
|
Summary: Holding the long position as the uptrend persists with price above EMA and SMA, positive MACD despite recent pullback, no immediate earnings or catalysts, and stable healthcare sector fundamentals without bearish news. Technicals are prioritized, and while there's a minor pullback from recent highs near $500, this appears as a healthy dip in an ongoing uptrend rather than a reversal, supported by no volume capitulation and price holding above key support levels like $458.85 from the rising trendline....
|
|
| 2025-09-02 | HOLD LONG |
|
Summary: Holding the long position as the uptrend continues with price above EMA and SMA, positive MACD momentum, no near-term earnings or catalysts, and stable fundamentals in healthcare amid no major bearish news....
|
|
| 2025-08-29 | HOLD LONG |
|
Summary: Continuing to hold the long position as the uptrend persists with price above both EMA and SMA, positive momentum toward $496.5 resistance, no earnings or catalysts within 3 days, and stable healthcare sector amid no major negative news....
|
|
| 2025-08-28 | HOLD LONG |
|
Summary: Holding the long position as the uptrend continues with price above EMA and SMA, positive MACD, no upcoming earnings or major catalysts within 3 days, and potential to approach $496.5 resistance again amid stable fundamentals in healthcare diagnostics....
|
|
| 2025-08-27 | HOLD LONG |
|
Summary: Holding the long position as the uptrend persists with price above EMA and SMA, positive MACD, no imminent earnings or catalysts, and potential upside to retest $496.5 resistance amid stable healthcare sector sentiment. There have been no frequent crossings of EMA/SMA or price in the past month (less than 2 times), and no volume capitulation flagged, so the trend remains clear and supportive of longs. The MACD is positive at 12.20, though below its signal line at 13.20, indicating momentum is still bullish but waning slightly; however, this doesn't override the trend. RSI at 57.85 is neutral, avoiding overbought territory, and Slow STO K/D at 77.93/83.88 suggests continued strength without immediate reversal risk. Support levels are noted at $390.50 (strong, multiple bounces) and $401.45, providing a safety net, while resistance at $496.50 aligns with prior highs where we exited profitably before—current price is below this, offering room for upside without buying at the top of the range....
|
|
| 2025-08-26 | HOLD LONG |
|
Summary: Holding the long position as the uptrend remains confirmed with price above EMA and SMA, positive MACD despite recent pullback, no earnings or catalysts within 3 days, and potential for retest of $496.5 resistance after dip....
|
|
| 2025-08-25 | HOLD LONG |
|
Summary: Holding the long position as the uptrend is confirmed with price above EMA and SMA, positive MACD, recent breakout above $496.5 resistance on 8/22, and no immediate catalysts or trend reversals warranting an exit after only 2 bars....
|
|
| 2025-08-22 | HOLD LONG |
|
Summary: Holding the long position as the uptrend remains confirmed with price above EMA and SMA, positive MACD, and recent breakout above resistance at $496.5 on increasing volume, targeting further upside over the next few weeks....
|
|
| 2025-08-21 | BUY |
|
Summary: Entering long on this dip in a confirmed uptrend after pulling back from resistance, with price above EMA and SMA, positive MACD, and a better entry price than recent exit. We exited the prior long yesterday at 494.81 near the $496.5 resistance with overbought STO, but today's pullback to 484 provides a much better entry price (about 2% lower) and a changed circumstance as it failed to hold above resistance but remains supported above key levels like $401.45 and rising trendlines around $483-492. No volume capitulation flagged recently, and the trend isn't unclear with infrequent crossings in the past month....
|
|
| 2025-08-20 | SOLD |
|
Summary: TMO is approaching key resistance at $496.5 with overbought STO and failure to sustain above it, prompting exit of the long position at $495.22 for profit realization before potential pullback, no upcoming catalysts....
|
|
| 2025-08-19 | HOLD LONG |
|
Summary: TMO continues in a strong uptrend with price breaking above $496 resistance on positive momentum, no upcoming catalysts or exit signals, holding the long position from $466.71 for further upside potential....
|
|
| 2025-08-18 | HOLD LONG |
|
Summary: TMO remains in a clear uptrend with price above both EMA and SMA, no exit signals or upcoming catalysts, holding the long position from $466.71 as it approaches $496 resistance with positive momentum....
|
|
| 2025-08-15 | HOLD LONG |
|
Summary: TMO continues in a strong uptrend with price above EMA and SMA, no exit signals like volume capitulation or catalysts, holding the profitable long from $466.71 as it nears $496 resistance....
|
|
| 2025-08-14 | HOLD LONG |
|
Summary: TMO remains in a clear uptrend with price above both EMA and SMA, holding the long position from $466.71 as it approaches $496 resistance without any exit signals like volume capitulation or upcoming catalysts....
|
|
| 2025-08-13 | HOLD LONG |
|
Summary: TMO continues in a strong uptrend with price above EMA and SMA, climbing towards $496 resistance after post-earnings gap, with no catalysts or volume capitulation signaling an exit yet....
|
|
| 2025-08-12 | HOLD LONG |
|
Summary: TMO remains in a clear uptrend with price above both EMA and SMA, rebounding strongly from recent support around $450 toward resistance near $496 after the post-earnings gap, with no volume capitulation or immediate catalysts suggesting an exit....
|
|
| 2025-08-11 | HOLD LONG |
|
Summary: TMO continues in a clear uptrend with price above both EMA and SMA, rebounding from recent support near $450 toward resistance around $477 after a post-earnings gap up, with no immediate catalysts or earnings to disrupt the hold....
|
|
| 2025-08-08 | HOLD LONG |
|
Summary: TMO remains in a clear uptrend with price above both EMA and SMA after a strong post-earnings gap up, pulling back to support near $450 before rebounding toward resistance around $477, supported by positive Q2 results and no near-term catalysts, suggesting potential for further upside over the next few weeks....
|
|
| 2025-08-07 | HOLD LONG |
|
Summary: Despite a recent pullback, TMO maintains an uptrend with price above both EMA and SMA, supported by strong Q2 earnings beats and positive institutional activity like Parnassus Investments adding shares, suggesting potential rebound toward $480 resistance over the next few weeks....
|
|
| 2025-08-06 | HOLD LONG |
|
Summary: Despite the recent pullback, TMO remains in a clear uptrend with price above both EMA and SMA, bolstered by strong Q2 earnings performance including revenue and EPS beats, and positive sentiment from sources like Seeking Alpha highlighting undervaluation and growth in pharma/biotech segments, positioning for a rebound toward $480 resistance over the coming weeks....
|
|
| 2025-08-05 | HOLD LONG |
|
Summary: The stock maintains a clear uptrend with price above both EMA and SMA, recent consolidation holding above key supports post-earnings beat, and positive momentum from Q2 results suggesting further upside toward $480 resistance over the coming weeks....
|
|
| 2025-08-04 | HOLD LONG |
|
Summary: The stock remains in a clear uptrend with price above both EMA and SMA, recent pullback finding support without breaking key levels, and positive Q2 earnings momentum supporting further upside toward resistance around $482 over the next few weeks....
|
|
| 2025-08-01 | HOLD LONG |
|
Summary: The stock maintains a clear uptrend with price above both EMA and SMA, recent earnings beat and positive analyst sentiment supporting continued upside despite minor pullback, justifying holding the long position for at least another week targeting resistance near $482....
|
|
| 2025-07-31 | HOLD LONG |
|
Summary: The stock remains in a clear uptrend with price above both EMA and SMA, supported by recent Q2 earnings beat and positive analyst updates, justifying holding the long position for further upside potential over the coming weeks....
|
|
| 2025-07-30 | HOLD LONG |
|
Summary: The stock maintains a strong uptrend with price above EMA and SMA, supported by positive Q2 earnings beat, raised FY2025 guidance, and bullish momentum from recent highs, justifying continued holding for further upside over the next few weeks....
|
|
| 2025-07-29 | HOLD LONG |
|
Summary: The stock remains in a strong uptrend post-earnings breakout with price above both EMA and SMA, continued positive momentum from recent highs, and supportive news on innovations and raised guidance, suggesting holding for further upside over the coming weeks....
|
|
| 2025-07-28 | HOLD LONG |
|
Summary: Continuing strong uptrend post-earnings beat with positive analyst updates and no immediate catalysts to disrupt momentum....
|
|
| 2025-07-25 | HOLD LONG |
|
Summary: The stock remains in a strong uptrend post-earnings breakout with positive FY2025 guidance and analyst upgrades supporting further upside over the coming weeks....
|
|
| 2025-07-24 | HOLD LONG |
|
Summary: Continue holding the long position as the uptrend remains intact post-earnings beat, with price above EMA and SMA, and positive guidance suggesting further upside over the coming weeks....
|
|
| 2025-07-23 | BUY |
|
Summary: The stock gapped up significantly on strong Q2 earnings beat with revenue and EPS exceeding estimates, breaking out of a downtrend on high volume into a clear uptrend, suggesting further upside over the next few weeks....
|
|
| 2025-07-22 | COVERED |
|
Summary: Exiting the short position due to upcoming earnings on 7/23/2025 to avoid holding through potential volatility, as the trend has shifted to uptrend with price above both EMA and SMA, and no strong bearish catalysts justify the risk....
|
|
| 2025-07-18 | SHORT |
|
Summary: The stock is in a sustained downtrend under a falling resistance trendline at $429, with recent rejection at $434 and bearish MACD crossover, suggesting further downside to support at $390 for a favorable risk/reward short setup holding weeks....
|
|